Harrow HROW
NASDAQ HROW
$37.70 -0.15 (-0.40%)
As of: Sep 9, 2026 · 12:50 PM EDT

Harrow (HROW) Research & Development (2010 - 2026)

Harrow (HROW) posted Research & Development of $8.1 million for Q2 2026, up 36.93% on a QoQ basis from $5.9 million in Q1 2026, and up 181.45% year-over-year from $2.9 million in Q2 2025.

Analysis

Harrow (HROW) Research & Development (2010 - 2026) Analysis & Trends

Harrow has reported Research & Development for 17 years, with the latest figure at $8.1 million in Q2 2026.

  • On a quarterly basis, Research & Development rose 181.45% year-over-year to $8.1 million in Q2 2026; TTM through Jun 2026 was $29.0 million, a 124.52% increase from a year earlier, with the FY2025 full-year figure at $20.9 million, up 71.22% from the prior year.
  • Research & Development was $8.1 million for Q2 2026 at Harrow, up from $5.9 million in the prior quarter.
  • The five-year high for Research & Development was $11.7 million in Q4 2025, with the low at $658000.0 in Q1 2022.
  • Average Research & Development over 5 years is $3.2 million, with a median of $2.6 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: Research & Development slumped 87.35% in 2022, then soared 374.54% in 2023.
  • Over 5 years, Research & Development stood at $703000.0 in 2022, then soared by 374.54% to $3.3 million in 2023, then jumped by 42.54% to $4.8 million in 2024, then jumped by 146.54% to $11.7 million in 2025, then sank by 31.14% to $8.1 million in 2026.
  • The last three Research & Development figures came in at $8.1 million (Q2 2026), $5.9 million (Q1 2026), and $11.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 642.70 Bn 621.95 Bn 17.26 Bn 3.65 Bn
2 AbbVie 440.80 Bn 434.23 Bn 12.70 Bn 2.34 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 266.37 Bn 258.68 Bn 11.24 Bn -2.85 Bn
5 Pfizer 158.89 Bn 147.19 Bn 10.94 Bn 2.81 Bn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -2.60 Bn
7 Revolution Medicines 44.38 Bn 44.38 Bn - 394.92 Mn
8 Incyte 25.28 Bn 20.74 Bn 1.57 Bn 516.95 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 146.30 Mn
10 Harrow 1.41 Bn 1.32 Bn 50.36 Mn 8.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.07 Mn
Mar 31, 2026 5.90 Mn
Dec 31, 2025 11.72 Mn
Sep 30, 2025 3.32 Mn
Jun 30, 2025 2.87 Mn
Mar 31, 2025 3.03 Mn
Dec 31, 2024 4.76 Mn
Sep 30, 2024 2.27 Mn
Jun 30, 2024 3.05 Mn
Mar 31, 2024 2.15 Mn
Dec 31, 2023 3.34 Mn
Sep 30, 2023 1.42 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 734,000.00
Dec 31, 2022 703,000.00
Sep 30, 2022 775,000.00
Jun 30, 2022 914,000.00
Mar 31, 2022 658,000.00
Dec 31, 2021 3.94 Mn
Sep 30, 2021 6.13 Mn